News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sophiris Bio Inc. (SHS.TO) Adds Gerald T. Proehl To Its Board Of Directors


3/20/2014 6:41:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company developing a clinical stage, targeted treatment for the symptoms of benign prostatic hyperplasia (BPH) or enlarged prostate, today announced the appointment of Gerald T. Proehl to its board of directors effective March 19, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES